Results 161 to 170 of about 1,874,188 (207)

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.

Lancet Infect Dis
Leitner DR, Walsh SR, Suzuki M, Desjardins M, Hannaford A, Sherman AC, Levine H, Carr L, Hammerness E, Osaki A, Sullivan E, Wang B, Balazs GI, Park Chang JB, Slater DM, Puri N, Kuehl CJ, Chen WH, Harris JB, Piantadosi S, Baden LR, Waldor MK, PanChol study group.   +22 more
europepmc   +1 more source

COVID-19 Vaccine Hesitancy and Associated Oral Cholera Vaccine Hesitancy in a Cholera-Endemic Country: A Community-Based Cross-Sectional Study in the Democratic Republic of Congo. [PDF]

Vaccines (Basel)
Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Ashuza GS, Tamuzi JL, Ndwandwe D, Iwu-Jaja C, Wiysonge CS, Katoto PDMC.   +9 more
europepmc   +1 more source

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial

Leitner DR, Walsh SR, Suzuki M, Desjardins M, Hannaford A, Sherman AC, Levine H, Carr L, Hammerness E, Osaki A, Sullivan E, Wang B, Balazs GI, Park Chang JB, Slater DM, Puri N, Kuehl CJ, Chen WH, Harris JB, Piantadosi S, Baden LR, Waldor MK.   +21 more
europepmc   +1 more source

Effectiveness of a single dose of oral cholera vaccine: findings from epidemiological and genomic surveillance ofVibrio Choleraein the Democratic Republic of the Congo (PICHA7 Program)

George CM, Namunesha A, Endres K, Felicien W, Sanvura P, Bisimwa J, Perin J, Bengehya J, Maheshe G, Cikomola C, Bisimwa L, Mwishingo A, Sack DA, Domman D.   +13 more
europepmc   +1 more source

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

Lancet Glob Health
Song KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA.   +26 more
europepmc   +1 more source

Statement on oral cholera vaccination.

Canada communicable disease report = Releve des maladies transmissibles au Canada, 1999
openaire   +1 more source

Oral cholera vaccines--a call for action.

The Indian journal of medical research, 2010
Dipika, Sur, G Balakrish, Nair, Anna Lena, Lopez, John D, Clemens, Viswa Mohan, Katoch, Nirmal Kumar, Ganguly   +5 more
openaire   +1 more source

High hopes for oral cholera vaccine

Bulletin of the World Health Organization, 2010
doaj  

Herd Immunity Conferred by Killed Oral Cholera Vaccines in Bangladesh: A Reanalysis

Lancet, The, 2005
BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are ...
John David Clemens, David A. Sack, Mohammed Yunus   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Oral Cholera Vaccine and Integrated Cholera Control in Haiti

Lancet, The, 2012
Louise C Ivers, Paul Farmer
exaly   +3 more sources